What is the treatment for multiple sclerosis (MS)?
No one chooses to have MS. But you can choose how to manage it.
Our understanding of MS and how it progresses has increased substantially, since the first MS treatment was introduced around 30 years ago.1
Now, there are more treatment options than ever before.2
Mike
Katie
Mike
When considering how to manage your MS, now is the time for action. MS progresses right from the start, even if you don’t experience new symptoms.3,4 So, the sooner treatment is started, the sooner you can slow down disease progression3 and manage your MS in a way that suits you .
Your experience of MS is unique to you. So, when considering your options, think about your lifestyle and what you want to achieve now, and in the years to come.1
First, take some time to learn more about the treatment approaches and types of treatment available to you, then decide with your healthcare team what would work best to help you face your MS head on.
Stay ahead of your MS. Slow progression from the start.
Starting treatment as soon as possible after an MS diagnosis can help slow down the activity of the disease and delay the long-term worsening of symptoms.3 The latest research shows us that early action is the most effective treatment approach.4
This interactive graph* shows how the worsening of MS symptoms can be slowed down when treatment is started soon after diagnosis compared to delaying treatment.
*Adapted from the figure included in the ‘Brain health: time matters in multiple sclerosis’ report3
Early Treatment
Treatment started later
The following links will help you to learn more about underlying disease progression and the importance of early treatment:
More articles on ways to manage your MS that you may find interesting.
We know more about MS than ever before. Now you can learn more about it, too.
MS can change your life. But it doesn’t have to define it.
- Paty DW, et al. Neurology. 1993;43:662–7.
- MS Society. Treatments and therapies. https://www.mssociety.org.uk/about-ms/treatments-and-therapies [accessed June 2020].
- Giovannoni G, et al. Mult Scler Relat Disord. 2016;9(Suppl 1):S5–48.
- Stankiewicz JM, et al. Neurol Neuroimmunol Neuroinflamm. 2020;7:e636.